Edwards Lifesciences (EW) Short-term Investments (2016 - 2025)
Edwards Lifesciences (EW) has 15 years of Short-term Investments data on record, last reported at $1.3 billion in Q4 2025.
- For Q4 2025, Short-term Investments rose 38.42% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, up 38.42%, while the annual FY2025 figure was $1.3 billion, 38.42% up from the prior year.
- Short-term Investments reached $1.3 billion in Q4 2025 per EW's latest filing, up from $1.2 billion in the prior quarter.
- Across five years, Short-term Investments topped out at $1.3 billion in Q4 2025 and bottomed at $156.4 million in Q1 2021.
- Average Short-term Investments over 5 years is $566.5 million, with a median of $469.8 million recorded in 2023.
- Peak YoY movement for Short-term Investments: plummeted 57.52% in 2021, then skyrocketed 197.31% in 2022.
- A 5-year view of Short-term Investments shows it stood at $604.0 million in 2021, then fell by 26.11% to $446.3 million in 2022, then grew by 12.14% to $500.5 million in 2023, then surged by 85.95% to $930.7 million in 2024, then skyrocketed by 38.42% to $1.3 billion in 2025.
- Per Business Quant database, its latest 3 readings for Short-term Investments were $1.3 billion in Q4 2025, $1.2 billion in Q3 2025, and $789.4 million in Q2 2025.